Phadungvorasart W, Kulkantrakorn K. Janus kinase 1/2 inhibition with Baricitinib for treatment of anti-signal recognition particle necrotizing autoimmune myositis: a case report. BKK Med J [Internet]. 2023 Sep. 30 [cited 2023 Dec. 10];19(2):121. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/259860